Neogen Corp (FRA:NG2)
€ 15 0.6 (4.17%) Market Cap: 3.32 Bil Enterprise Value: 4.04 Bil PE Ratio: 0 PB Ratio: 1.13 GF Score: 76/100

Neogen Corp at William Blair Growth Stock Conference Transcript

Jun 06, 2023 / 09:00PM GMT
Release Date Price: €17 (-0.58%)
Brandon Vazquez
William Blair & Co. LLC - Analyst

Hi, everyone. Thanks for joining us today at the William Blair Growth Stock Conference. My name is Brandon Vazquez and I am a research analyst here at William Blair that covers healthcare, some medical device, dental, and animal and food safety names as well.

I'm required to inform you from a compliance perspective, for a complete list of research disclosures or potential conflicts of interest, please visit our website at williamblair.com. And I'm excited to have with us here today CEO, John Adent; and CFO, Dave Naemura of Neogen.

And with that, I'll let John take over and give a presentation for us.

John Adent
Neogen Corporation - CEO & President

Yeah. Thank you, Brandon. So thank you all for being here. We're glad to be able to present, tell you a little bit more about the Neogen story. As Brandon said, I'm John Adent. I'm President and CEO of Neogen.

Just a quick reminder that the presentation today, we're going to have forward-looking statements. So my attorney said,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot